Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1Classical hematology 1

Conditions

Gliosarcoma 29Glioblastoma 29Central Nervous System Neoplasms 23Brain Neoplasms 17Astrocytoma 15Glioma 12Oligodendroglioma 9Ependymoma 6Lymphoma, Large B-Cell, Diffuse 5Burkitt Lymphoma 5Recurrence 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Dendritic Cell Sarcoma, Interdigitating 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroectodermal Tumors, Primitive 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Leukemia, Myeloid, Acute 3Hodgkin Disease 3Congenital Abnormalities 3Waldenstrom Macroglobulinemia 2Testicular Neoplasms 2Neuroblastoma 2Meningioma 2

Interventions

Cyclophosphamide 10fludarabine phosphate 9Mycophenolic Acid 8Antilymphocyte Serum 8Cyclosporine 7Methotrexate 6Filgrastim 6Cord Blood Stem Cell Transplantation 6Busulfan 6Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Whole-Body Irradiation 4Radiotherapy 4Methylprednisolone 4Melphalan 4Etoposide 3thymoglobulin 2Sirolimus 2Polymerase Chain Reaction 2Flow Cytometry 2Amplified Fragment Length Polymorphism Analysis 2sargramostim 1liposomal amphotericin B 1Voriconazole 1Valacyclovir 1Stem Cell Transplantation 1Rituximab 1Prednisone 1Pentetic Acid 1Ondansetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Carmustine × Sarcoma × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡